Fundraising FoxS32 — 2024 Investments
6 investments dated 2024 · listed companies and verified rows first · show all
humans& is a frontier AI lab focused on building human-centric AI systems that prioritize people and their relationships, emphasizing innovations in reinforcement learning, memory, and user understanding to create AI that strengthens organizations and communities.
AI & Machine LearningEnterprise SoftwareSaaSEl Segundo, US
Eric Zelikman(Founder)inNoah Goodman(Founder)inGeorges Harik(Founder)Alaarif Nooruldeen(Executive Officer, Director)Andi Peng(Founder)Ray Ramadorai(Founder)
Co-investorsGV (Google Ventures)SV AngelNVIDIAA.Capital VenturesAlumni VenturesBloomberg Beta+19 more
A new type of biodiscovery, discovering and harnessing nature's most valuable proteins
London, GB
Oliver Vince(Founder)inGlen Gowers(Founder)inGlen Gowers Oliver Vince(Founder)
Co-investorsBlue Horizon CorporationHummingbird VenturesNVenturesNVIDIASection 32Systemiq Capital+7 more
Nusano produces medical radioisotopes for use in theranostic compounds and cancer treatment applications.
BiotechDeep TechHealthtechMedical DevicesWest Valley City, US
Howard C. Lewin(Co-founder & Chief Product Development Officer)inGlenn B. Rosenthal(Co-founder & Chief Technology Officer)in
Co-investorsWasatch Equity PartnersSection 32BrightEdge
Pomelo is a modular, API-first payment infrastructure platform powered by AI that enables the issuance, processing, and management of credit and debit cards.
AI & Machine LearningFintechSaaSBuenos Aires, AR
Gastón Irigoyen(CEO & Co-Founder)inJuan Fantoni(CCO & Co-Founder)inHernán Corral(CPO & Co-Founder)in
Co-investorsAlter GlobalBoxGroupClocktower VenturesFJ LabsGraph VenturesIndex Ventures+22 more
Biotechnology company developing blood-based diagnostic tests for neurological disorders and early-stage cancer.
Cambridge, US
Co-investorsAlumni VenturesARCH Venture PartnersClavystBioPolaris Partners
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
Ema Unlimited, Inc.
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.